Janux Therapeutics Inc (JANX)
46.50
-2.46
(-5.02%)
USD |
NASDAQ |
Nov 21, 16:00
45.80
-0.70
(-1.51%)
Pre-Market: 08:00
Janux Therapeutics Price to Book Value: 3.720 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 3.720 |
| November 20, 2024 | 3.916 |
| November 19, 2024 | 3.920 |
| November 18, 2024 | 3.849 |
| November 15, 2024 | 3.900 |
| November 14, 2024 | 4.088 |
| November 13, 2024 | 4.159 |
| November 12, 2024 | 4.227 |
| November 11, 2024 | 4.294 |
| November 08, 2024 | 4.313 |
| November 07, 2024 | 4.336 |
| November 06, 2024 | 4.391 |
| November 05, 2024 | 4.422 |
| November 04, 2024 | 4.469 |
| November 01, 2024 | 4.339 |
| October 31, 2024 | 4.307 |
| October 30, 2024 | 4.463 |
| October 29, 2024 | 4.324 |
| October 28, 2024 | 4.336 |
| October 25, 2024 | 4.260 |
| October 24, 2024 | 4.252 |
| October 23, 2024 | 4.128 |
| October 22, 2024 | 4.212 |
| October 21, 2024 | 4.028 |
| October 18, 2024 | 3.991 |
| Date | Value |
|---|---|
| October 17, 2024 | 3.973 |
| October 16, 2024 | 3.941 |
| October 15, 2024 | 4.207 |
| October 14, 2024 | 3.937 |
| October 11, 2024 | 3.953 |
| October 10, 2024 | 3.767 |
| October 09, 2024 | 3.669 |
| October 08, 2024 | 3.584 |
| October 07, 2024 | 3.522 |
| October 04, 2024 | 3.591 |
| October 03, 2024 | 3.523 |
| October 02, 2024 | 3.466 |
| October 01, 2024 | 3.550 |
| September 30, 2024 | 3.624 |
| September 27, 2024 | 3.668 |
| September 26, 2024 | 3.698 |
| September 25, 2024 | 3.798 |
| September 24, 2024 | 3.853 |
| September 23, 2024 | 3.986 |
| September 20, 2024 | 3.982 |
| September 19, 2024 | 3.964 |
| September 18, 2024 | 3.833 |
| September 17, 2024 | 3.923 |
| September 16, 2024 | 3.957 |
| September 13, 2024 | 3.967 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7737
Minimum
Nov 09 2023
6.684
Maximum
Feb 27 2024
2.329
Average
1.940
Median
Price to Book Value Benchmarks
| Dynavax Technologies Corp | 2.384 |
| Krystal Biotech Inc | 5.918 |
| NovaBay Pharmaceuticals Inc | 3.299 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
Price to Book Value Related Metrics
| PS Ratio | 182.49 |
| Price | 46.50 |
| Earnings Yield | -2.49% |
| Market Cap | 2.440B |